Infusion Therapy Archives - Page 2 of 2

Lundbeck buys Alder for $2 billion, eyes ‘blockbuster’ migraine therapy

Acquisitions, Analysts, Antibodies, Business, Deals, FDA, IV Infusion, Migraine, Potential Blockbusters

Denmark’s Lundbeck agreed to buy Alder BioPharmaceuticals in a deal valued at almost $2 billion, hoping to reap profits from a potential blockbuster migraine drug.

September 16, 2019/by Reuters Health

U.S. FDA Approves Baxter’s Ready-To-Use Insulin for IV Infusion Myxredlin

Approvals, FDA, FDA/Regulatory, Glycemic Control, Hospitals, Infusion Therapy

Baxter International Inc. announced the U.S. Food and Drug Administration approval of Myxredlin (Insulin Human in 0.9% Sodium Chloride Injection).

July 22, 2019/by Business Wire